We are live on ! Find out more
AFM

Anson Funds Management Portfolio holdings

AUM $2.29B
1-Year Est. Return 370.24%
This Fund
S&P 500
This Quarter Est. Return
+9.11%
1 Year Est. Return
+370.24%
3 Year Est. Return
+1,243.07%
5 Year Est. Return
+867.54%
10 Year Est. Return
+12,575.88%
AUM
$320M
AUM Growth
-$146M
Cap. Flow
-$159M
Cap. Flow %
-49.86%
Top 10 Hldgs %
67.17%
Holding
109
New
50
Increased
6
Reduced
14
Closed
21

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$20.8M
2
BXE
Bellatrix Exploration Ltd.
BXE
+$5.02M
3
CAT icon
Caterpillar
CAT
+$4.53M
4
HIHO icon
Highway Holdings
HIHO
+$2.33M
5
LITS
Lite Strategy Inc
LITS
+$2.15M

Top Sells

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$26.8M
2
PHYS icon
Sprott Physical Gold
PHYS
+$11.1M
3
CXW icon
CoreCivic
CXW
+$7.03M
4
TK icon
Teekay
TK
+$3.08M
5
PERY
Perry Ellis International Inc
PERY
+$2.24M

Sector Composition

Rank Sector Weight
1 Financials 9.95%
2 Energy 9.29%
3 Technology 6.39%
4 Materials 4.86%
5 Consumer Discretionary 4.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CBMXW
51
DELISTED
CombiMatrix Corporation Warrant
CBMXW
$327K 0.1%
123,238
-10,961
-8% -$6.46K
SGMO
52
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$306K 0.1%
+100,209
New +$365K
IZEA icon
53
IZEA Worldwide
IZEA
$60.4M
$301K 0.09%
+16,684
New +$331K
ARCT icon
54
Arcturus Therapeutics
ARCT
$163M
$300K 0.09%
+20,425
New +$305K
TUES
55
DELISTED
Tuesday Morning Corp
TUES
$295K 0.09%
+54,611
New +$294K
REFR icon
56
Research Frontiers
REFR
$15.2M
$289K 0.09%
+158,937
New +$329K
SLNO
57
DELISTED
Soleno Therapeutics
SLNO
$288K 0.09%
+4,740
New +$328K
DRNA
58
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$287K 0.09%
+99,658
New +$354K
NVTR
59
DELISTED
Nuvectra Corporation Common Stock
NVTR
$283K 0.09%
+56,253
New +$317K
ENLV icon
60
Enlivex Ltd
ENLV
$37.7M
$282K 0.09%
+451
New +$382K
ONCS
61
DELISTED
OncoSec Medical Incorporated
ONCS
$280K 0.09%
+1,033
New +$355K
ECYT
62
DELISTED
Endocyte, Inc. Common Stock
ECYT
$276K 0.09%
+108,426
New +$311K
CSCI
63
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$275K 0.09%
+568
New +$212K
IMUX icon
64
Immunic
IMUX
$182M
$270K 0.08%
+155
New +$339K
BNBX
65
DELISTED
BNB PLUS CORP
BNBX
– –
0
– –
SEEL
66
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$263K 0.08%
2
-2
-50% -$468K
FLNA
67
Filana Therapeutics
FLNA
$42.7M
$262K 0.08%
+65,667
New +$305K
PPLT
68
abrdn Physical Platinum Shares ETF
PPLT
$1.83B
$259K 0.08%
30,000
– –
ABUS icon
69
Arbutus Biopharma
ABUS
$871M
$257K 0.08%
+105,085
New +$306K
LOV
70
DELISTED
Spark Networks SE American Depositary Shares
LOV
$251K 0.08%
+299,107
New +$372K
UQM
71
DELISTED
UQM Technologies, Inc.
UQM
$243K 0.08%
+565,204
New +$292K
IMUC.WS
72
DELISTED
ImmunoCellular Therapeutics Ltd.
IMUC.WS
$240K 0.08%
+117,188
New +$39.9K
CATX icon
73
Perspective Therapeutics
CATX
$327M
$235K 0.07%
+40,490
New +$248K
EYPT icon
74
EyePoint Inc
EYPT
$1B
$225K 0.07%
+13,146
New +$266K
SBBP
75
DELISTED
Strongbridge Biopharma plc.
SBBP
$221K 0.07%
+92,219
New +$376K
1 2
3
4 5

Similar funds

LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
MA
MCF Advisors Covington, Kentucky $2.28B AUM 14.87% 1-Year Est. Return
ST
Smithfield Trust Pittsburgh, Pennsylvania $2.3B AUM 14.87% 1-Year Est. Return
GCP
Greenoaks Capital Partners Orinda, California $2.3B AUM 19.87% 1-Year Est. Return
LCM
Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
7WCP
71 West Capital Partners Boston, Massachusetts $2.27B AUM
LFM
LGT Fund Management Vaduz, Liechtenstein $2.3B AUM 22.66% 1-Year Est. Return

Anson Funds Management's Q4 2016 Portfolio in Review

As of Q4 2016, Anson Funds Management held 109 positions worth $320M, down 31% from $465M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Anson Funds Management withdrew a net $159M in Q4 2016, closing 21 positions and reducing 14 holdings. Its most notable exit was Sprott Physical Gold, an estimated $11.1M position sold in full.

By sector, the portfolio is most concentrated in Financials at 10% of assets, up from 9.7% a quarter earlier, followed by Energy and Technology.

Against the trend, Anson Funds Management opened a new position in Caterpillar worth $4.64M.

  • Anson Funds Management's largest Q4 2016 buy was Caterpillar: 50,000 shares worth $4.64M.
  • Anson Funds Management added most to State Street SPDR S&P 500 ETF Trust in Q4 2016, an estimated $20.8M increase.
  • Anson Funds Management's biggest Q4 2016 reduction was Bank of America, cutting an estimated $26.8M.
  • Anson Funds Management fully exited Sprott Physical Gold in Q4 2016, selling an estimated $11.1M.
  • Anson Funds Management's ten largest holdings make up 67% of its $320M portfolio in Q4 2016.
  • Anson Funds Management opened 50 new positions and closed 21 in Q4 2016.
  • Anson Funds Management's portfolio value fell 31% quarter-over-quarter to $320M.

Based on Anson Funds Management's 13F filing for Q4 2016, filed 14 Feb 2017.